Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, La Jolla, San Diego, CA 92093-0901, USA.
Breast Cancer Res Treat. 2011 Jun;127(2):541-7. doi: 10.1007/s10549-010-1236-x. Epub 2010 Nov 3.
Physical health-related quality of life scores have been, inconsistently, associated with breast cancer prognosis. This analysis examined whether change in physical health scores were related to outcomes in women with a history of breast cancer. 2343 breast cancer survivors in a randomized diet trial provided self-reported assessment of physical health-related quality of life at baseline and year 1. Based on change in physical health score, participants were grouped into subpopulations of decreased physical health, no/minimal changes, and increased physical health. Cox regression analysis assessed whether change in physical health (from baseline to year 1) predicted disease-free and overall survival; hazard ratio (HR) was the measure of association. There were 294 additional breast cancer events and 162 deaths among women followed for 7.3 years. Improvements in physical health were associated with younger age, lower BMI, being employed, not receiving tamoxifen, lower physical activity, and lower baseline physical and mental health. There was no association of change in physical health with additional breast cancer events or mortality among women diagnosed ≤ 2 years before study enrollment. However, among women who entered the study >2 years post-diagnosis, the HR for increased compared to decreased physical health was 0.38 (95% CI, 0.16-0.85) for all-cause mortality. These results appear to support testing an intervention to improve physical health in breast cancer patients among patients after the acute stage of treatment.
身体健康相关的生活质量评分与乳腺癌的预后不一致。本分析研究了身体健康评分的变化是否与乳腺癌病史女性的结局相关。2343 名参加随机饮食试验的乳腺癌幸存者在基线和第 1 年时提供了身体健康相关生活质量的自我报告评估。根据身体健康评分的变化,将参与者分为身体健康下降、无/最小变化和身体健康增加的亚人群。Cox 回归分析评估了身体健康(从基线到第 1 年)的变化是否预测无病生存和总体生存;风险比(HR)是关联的衡量标准。在随访 7.3 年后,女性中有 294 例额外的乳腺癌事件和 162 例死亡。身体健康的改善与年龄较小、BMI 较低、就业、未接受他莫昔芬治疗、较低的身体活动量以及较低的基线身体和心理健康有关。身体健康的变化与≤2 年前入组研究的女性的乳腺癌事件或死亡率之间没有关联。然而,对于在诊断后>2 年进入研究的女性,与身体健康下降相比,身体健康增加的 HR 为所有原因死亡率的 0.38(95%CI,0.16-0.85)。这些结果似乎支持在治疗的急性期后对乳腺癌患者进行改善身体健康的干预措施进行测试。